Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status

SARS-CoV-2 is causing an increasing number of deaths worldwide because no effective treatment is currently available. Remdesivir has shown in vitro activity against coronaviruses and is a possible antiviral treatment for SARS-CoV-2 infection. This prospective (compassionate), open-label study of rem...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharmacol Res
Egile Nagusiak: Antinori, Spinello, Cossu, Maria Vittoria, Ridolfo, Anna Lisa, Rech, Roberto, Bonazzetti, Cecilia, Pagani, Gabriele, Gubertini, Guido, Coen, Massimo, Magni, Carlo, Castelli, Antonio, Borghi, Beatrice, Colombo, Riccardo, Giorgi, Riccardo, Angeli, Elena, Mileto, Davide, Milazzo, Laura, Vimercati, Stefania, Pellicciotta, Martina, Corbellino, Mario, Torre, Alessandro, Rusconi, Stefano, Oreni, Letizia, Gismondo, Maria Rita, Giacomelli, Andrea, Meroni, Luca, Rizzardini, Giuliano, Galli, Massimo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier Ltd. 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7212963/
https://ncbi.nlm.nih.gov/pubmed/32407959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2020.104899
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak